WHO ICTRP trial
ESTUDIO ALEATORIZADO, DOBLE CIEGO Y CONTROLADO CON PLACEBO PARA EVALUAR LA…
EUCTR2010-019505-42-ES · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2010-019505-42-ES |
|---|---|
| Public title | ESTUDIO ALEATORIZADO, DOBLE CIEGO Y CONTROLADO CON PLACEBO PARA EVALUAR LA EFICACIA Y SEGURIDAD DE LEGALON SIL EN EL TRATAMIENTO DE LA RECURRENCIA DE VHC EN EL INJERTO DE PACIENTES SOMETIDOS A UN TRASPLANTE ORTOTÓPICO DE HÍGADO / A randomized, double-blind, placebo controlled, study to investigate the efficacy and safety of Legalon SIL for the treatment of HCV recurrence of the graft in orthotopic liver transplant patients |
| Scientific title | ESTUDIO ALEATORIZADO, DOBLE CIEGO Y CONTROLADO CON PLACEBO PARA EVALUAR LA EFICACIA Y SEGURIDAD DE LEGALON SIL EN EL TRATAMIENTO DE LA RECURRENCIA DE VHC EN EL INJERTO DE PACIENTES SOMETIDOS A UN TRASPLANTE ORTOTÓPICO DE HÍGADO / A randomized, double-blind, placebo controlled, study to investigate… |
| Primary sponsor | Rottapharm SpA |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Spain |
| Conditions | Pacientes de 18-70 años afectados por VHC en espera de de un trasplante ortotópico de hígado / 18-70 years old patients affected by HCV awaiting orthotopic liver transplantation |
| Interventions | Trade Name: LEGALON SIL Pharmaceutical Form: INN or Proposed INN: SILIBININA SUCCINATO SODIO CAS Number: 0 Other descriptive name: SILIBININA SUCCINATO SODIO Concentration unit: mg milligram(s) Concentration type: equal Concentration… |
| Registration date | Apr 16, 2010 |
| Secondary IDs | LEG-SIL-LTX-03 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: